Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Administration of Ligilactobacillus Salivarius MP101 in an Elderly Nursing Home During the COVID Pandemics

NCT04922918 is registered in ClinicalTrials.gov with Universidad Complutense de Madrid as lead sponsor.

NCT NCT04922918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04922918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Administration of Ligilactobacillus Salivarius MP101 in an Elderly Nursing Home During the COVID Pandemics
Lead sponsor
Universidad Complutense de Madrid
Phase
Not applicable
Overall status
Unknown status
Start date
October 1, 2020
Completion date
July 1, 2021
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19